Pituitary ACTH Hypersecretion: Clinical Trials

2 trials for Pituitary ACTH Hypersecretion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Unknown 2
Phase 11Unknown 1

Follow Pituitary ACTH Hypersecretion: new trials by email Literature Review of Pituitary ACTH Hypersecretion trials Research Report on Pituitary ACTH Hypersecretion

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Targeted Therapy With Gefitinib in Patients With USP8-mutated Cushing's Disease
Gefitinib - Cushing's Disease, Corticotrophin Adenoma
Phase 2UnknownHuashan Hospital62015-06-012015-06-30
Preoperative Bexarotene Treatment for Cushing's Disease
Bexarotene - Cushing's Disease
Phase 1 / Phase 2UnknownUniversity of Virginia62008-11-012011-05-30

Broader conditions

Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Endocrine System Diseases (2)  ·  Hyperpituitarism (2)  ·  Hypothalamic Diseases (2)  ·  Nervous System Diseases (2)  ·  Pituitary Diseases (2)

Interventions

Bexarotene (1)  ·  Gefitinib (1)

Sponsors

Huashan Hospital (1)  ·  University of Virginia (1)

Countries

China (1)  ·  United States (1)

Top investigators

Mary Lee Vance, MD (1)  ·  Yao Zhao, MD (1)